XML 20 R15.htm IDEA: XBRL DOCUMENT  v2.3.0.11
STOCK-BASED COMPENSATION
6 Months Ended
Jul. 31, 2011
STOCK-BASED COMPENSATION [Abstract]  
STOCK-BASED COMPENSATION
10.  STOCK-BASED COMPENSATION

The Company's equity awards consist of stock options, SARs and RSUs. For a description of the Company's stock-based compensation plans, see Note 9 “Stock-Based Compensation” in Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended January 31, 2011.

Stock-Based Compensation

The following table sets forth reported stock-based compensation expense for the three and six months ended July 31, 2011 and 2010:

   
Three Months Ended
July 31,
  
Six Months Ended
July 31,
 
   
2011
  
2010
  
2011
  
2010
 
   
(in thousands)
  
(in thousands)
 
  Cost of maintenance, subscription and other revenue
 $59  $67  $111  $155 
  Cost of professional services
  170   129   295   343 
  Sales and marketing
  227   257   437   584 
  Research and development
  188   190   355   446 
  General and administrative
  518   638   1,076   1,223 
Total stock-based compensation expense
 $1,162  $1,281  $2,274  $2,751 

Option/SAR Information

The weighted average assumptions used to value SARs granted in the six months ended July 31, 2011 and 2010 are shown in the following table:


   
Six Months Ended
July 31,
 
   
2011
  
2010
 
Expected life in years (1)
  3.81   4.32 
Risk free interest rate (2)
  1.17%  1.73%
Volatility (3)
  66%  68%
Dividend rate (4)
  2.38%  2.23%
_____________________________________
 
(1)  
The expected life of SARs granted under the stock-based compensation plans is based on historical vested stock option and SAR exercise and post-vest forfeiture patterns and includes an estimate of the expected term for stock options and SARs that were fully vested and outstanding.
 
(2)  
The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of SARs in effect at the time of grant.
 
(3)  
The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company's common stock for a period equivalent to the expected life of the SARs, which it believes is representative of the expected volatility over the expected life of the SARs.
 
(4)  
The Company expects to continue paying quarterly dividends at the same rate as the three months ending on July 31, 2011.

The following table summarizes the activity for outstanding stock options and SARs for the fiscal year ended January 31, 2011 and the six months ended July 31, 2011:

 
 
 
 
Stock Options/
SARs
(in thousands)
  
Weighted
Average
Exercise
Price per
Share
  
Weighted
Average
Remaining
Contractual
Term (years)
  
 
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding at January 31, 2010
  2,214  $11.76     
 
 
Granted
  683   8.95       
Exercised
  (88)  6.44       
Expired
  (58)  10.42       
Forfeited
  (98)  8.93       
Outstanding at January 31, 2011
  2,653  $11.33       
Granted
  197   9.84       
Exercised
  (88)  7.81       
Expired
  (41)  14.46       
Forfeited
  (33)  9.36       
Outstanding at July 31, 2011
  2,688  $11.31   4.8  $3,369 
  Vested and expected to vest at July 31, 2011 (1)
  2,575  $11.40   4.7  $3,215 
  Vested and exercisable at July 31, 2011
  1,472  $13.03   3.3  $1,589 
_____________________________________

(1)
The expected-to-vest SARs are the result of applying the pre-vesting forfeiture rate assumptions to total outstanding SARs.

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the aggregate difference between the closing stock price of the Company's common stock based on the last trading day as of July 31, 2011 and the exercise price for in-the-money stock options and SARs) that would have been received by the holders if all stock options and SARs had been exercised on July 31, 2011. The total intrinsic value of stock options or SARs exercised in the three and six months ended July 31, 2011 was $121,000 and $211,000, respectively. The total intrinsic value of SARs exercised in the three and six months ended July 31, 2010 was $2,500 and $41,000, respectively. The weighted average grant date fair value per share of SARs granted in the three and six months ended July 31, 2011 was $4.15 and $4.14, respectively.  The weighted average grant date fair value per share of SARs granted in both the three and six months ended July 31, 2010 was $4.10.

At July 31, 2011, there was approximately $4.7 million of total unrecognized compensation cost related to unvested SARs. This cost is expected to be recognized over a weighted-average period of approximately 2.5 years.

RSU Information

The estimated fair value of RSUs was calculated based on the closing price of the Company's common stock on the date of grant, reduced by the present value of dividends foregone during the vesting period.

The following table summarizes the activity for RSUs for the fiscal year ended January 31, 2011 and the six months ended July 31, 2011:

   
 
 
RSUs
  
Weighted
Average
Grant Date
Fair Value
 
 
 
(in thousands)
    
        
Restricted stock at January 31, 2010
  475  $10.74 
Granted
  128   8.81 
Vested (1) 
  (165)  11.37 
Forfeited
  (3)  8.75 
Restricted stock at January 31, 2011
  435  $10.02 
Granted
  173   9.31 
Vested (1) 
  (111)  11.61 
Forfeited
  (7)  10.26 
Restricted stock at July 31, 2011
  490  $9.40 
_____________________________________

(1)
The number of RSUs vested includes shares withheld on behalf of employees to satisfy statutory tax withholding requirements.

The Company withholds, at the employee's election, a portion of the vested shares as consideration for the Company's payment of applicable employee income taxes. During the three months ended July 31, 2011, the Company withheld 28,000 shares for payment of these taxes at a value of $287,000. During the six months ended July 31, 2011, the Company withheld 33,000 shares for payment of these taxes at a value of $333,000.

Total unrecognized compensation cost related to RSUs was approximately $3.6 million as of July 31, 2011. This cost is expected to be recognized over a weighted-average period of approximately 2.7 years.